MORGAN STANLEY - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$17,597,361
-47.7%
1,089,620
+34.4%
0.00%
-33.3%
Q2 2023$33,637,828
+15.9%
810,550
+68.0%
0.00%0.0%
Q1 2023$29,023,245
-19.6%
482,594
-1.9%
0.00%
-25.0%
Q4 2022$36,091,427
-49.2%
492,044
-47.3%
0.00%
-60.0%
Q3 2022$70,981,000
-0.7%
934,213
-9.2%
0.01%
+11.1%
Q2 2022$71,469,000
+18.2%
1,028,338
+40.9%
0.01%
+12.5%
Q1 2022$60,451,000
-2.6%
729,649
-11.7%
0.01%0.0%
Q4 2021$62,046,000
-39.6%
826,414
-6.5%
0.01%
-42.9%
Q3 2021$102,716,000
-46.2%
884,185
+2.8%
0.01%
-44.0%
Q2 2021$190,746,000
+16.9%
859,912
-30.4%
0.02%
+4.2%
Q1 2021$163,233,000
-30.2%
1,234,928
-8.6%
0.02%
-33.3%
Q4 2020$233,718,000
+58.8%
1,350,654
+2.1%
0.04%
+28.6%
Q3 2020$147,217,000
+85.1%
1,322,589
-1.4%
0.03%
+55.6%
Q2 2020$79,519,000
-4.2%
1,340,954
+8.7%
0.02%
-21.7%
Q1 2020$83,045,000
-27.2%
1,233,217
-8.8%
0.02%
-14.8%
Q4 2019$114,008,000
+525.1%
1,352,896
+454.6%
0.03%
+440.0%
Q3 2019$18,239,000
+182.7%
243,919
+139.1%
0.01%
+150.0%
Q2 2019$6,452,000
+56.0%
102,027
+18.8%
0.00%
+100.0%
Q1 2019$4,137,000
-37.5%
85,877
-56.6%
0.00%
-50.0%
Q4 2018$6,619,000
-50.7%
197,704
-22.9%
0.00%
-33.3%
Q3 2018$13,434,000
+62.9%
256,408
-2.7%
0.00%
+50.0%
Q2 2018$8,247,000
+48.6%
263,506
+3.5%
0.00%0.0%
Q1 2018$5,549,000
+14.0%
254,562
+5.7%
0.00%
+100.0%
Q4 2017$4,866,000
+8.2%
240,920
+6.3%
0.00%0.0%
Q3 2017$4,498,000
+52.2%
226,624
+32.7%
0.00%0.0%
Q2 2017$2,955,000
+68.9%
170,777
-20.9%
0.00%
Q1 2017$1,750,000
-46.1%
215,994
-47.7%
0.00%
-100.0%
Q4 2016$3,244,000
+647.5%
413,352
+712.7%
0.00%
Q3 2016$434,000
-5.7%
50,859
+29.1%
0.00%
Q2 2016$460,000
-88.0%
39,410
-85.1%
0.00%
-100.0%
Q1 2016$3,828,000
-60.2%
264,385
-38.5%
0.00%
-66.7%
Q4 2015$9,619,000430,1770.00%
Other shareholders
NOVOCURE LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders